Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06640010

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 30

Sponsor: Mayo Clinic

Location: Mayo Clinic in Florida Jacksonville Florida

Summary

This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.

Eligibility Criteria

Inclusion Criteria: * Any patient \>= 18 years of age * Previously treated, planned or currently receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies Exclusion Criteria: * Inability on the part of the patient to understand the informed consent or be compliant with the protocol

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06640010). StuddyBuddy aggregates publicly available trial information.